Exchange Bulletin

Aurinia Pharmaceuticals Inc. (AUP) To Trade On Toronto Stock Exchange


June 13, 2014

Aurinia Pharmaceuticals Inc. (the "Company") - An application has been granted for the original listing in the Industrial category of 48,100,642 common shares of the Company, of which 31,357,082 common shares are issued and outstanding, and 16,743,560 common shares are reserved for issuance.

The common shares of the Company will be listed and posted for trading at the opening on Monday, June 16, 2014.

The Company is subject to the reporting requirements of Section 501 of the TSX Company Manual.

Stock Symbol: "AUP" CUSIP: 05156V 10 2 Trading Currency: CDN$



Temporary Market Maker: RBC Capital Markets
Other Markets: The common shares of the Company have been listed on TSX Venture Exchange since September 30, 2013 under the stock symbol "AUP". The common shares will be delisted from TSX Venture Exchange on Monday, June 16, 2014, upon commencement of trading on TSX.
Head Office Address: 1203 - 4464 Markham Street
Victoria, BC
V8Z 7X8
Email Address: mmartin@auriniapharma.com
Website: www.auriniapharma.com
Head Office Telephone Number: (250) 708-4272
Fax Number: (250) 744-2498
Investor Relations: Michael Martin
Tel: (250) 708-4272
Email: mmartin@auriniapharma.com
Chief Financial Officer: Dennis Bourgeault
Corporate Secretary: Stephen P. Robertson
Incorporation: The Company was incorporated under the Business Corporations Act (Alberta) on April 27, 2009 under the name "1465591 Alberta Ltd." On June 18, 2009, the Company changed its name to "Isotechnika Pharma Inc." and on October 23, 2013 to "Aurinia Pharmaceuticals Inc."
Fiscal Year End: December 31
Nature of Business: The Company is a biopharmaceutical company that is focused on the development of its novel therapeutic immunomodulating drug candidate, voclosporin, for the treatment of lupus nephritis.
Transfer Agent & Registrar: Computershare Trust Company of Canada at its principal offices in Calgary and Toronto.
Dividends: The Company has not paid any dividends or made any distributions since incorporation. The Company does not anticipate paying dividends in the foreseeable future.